iridium radioisotopes has been researched along with Benign Supratentorial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuta, T; Hiraki, Y; Matsumoto, K; Nakagawa, T; Ohmoto, T; Tada, E | 1 |
| Baillet, F; Boisserie, G; Cornu, P; Delattre, JY; Dormont, D; Hardiman, C; Hasboun, D; Mazeron, JJ; Simon, JM; Tep, B; Valery, CA | 1 |
1 trial(s) available for iridium radioisotopes and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas.
Topics: Adult; Antineoplastic Agents; Brachytherapy; Combined Modality Therapy; Female; Glioma; Humans; Iridium Radioisotopes; Male; Middle Aged; Nitrosourea Compounds; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Survival Rate | 1997 |
1 other study(ies) available for iridium radioisotopes and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Brachytherapy of glioblastoma recurring in previously irradiated territory: predictive value of tumor volume.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Brachytherapy; Brain Neoplasms; Female; Glioblastoma; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Retrospective Studies; Supratentorial Neoplasms; Survival Analysis | 2002 |